Transplantation Therapeutics Research: Talks about leading products and key unmet needs within the market

This leads to an anti-graft immune response that involves T cells invading the new tissue, multiplying, and recruiting more immune cells to the transplant site in order to remove this foreign body.

Pune, India - March 14, 2018 /MarketersMedia/ —

In 2015 a total of 127,000 transplantations were performed worldwide, an increase of 5.8% from 2014, with 33,000 of these occurring in the EU and 32,000 in the US. Approximately 60% of these were kidney transplants, with liver, heart, lung, pancreas and small bowel transplantations accounting for the other most common procedures (Dominguez-Gil and Matesanz, 2017). When a graft is transplanted from a genetically non-identical individual, the recipient’s immune system recognizes the graft as foreign.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-transplantation-therapeutics-a-highly-innovative-pipeline-with-a-range-of-adaptive-and-innate-immune-targeting-programs-focusing-on-graft-versus-host-disease-and-kidney-transplantation
Reasons To Buy
• Appreciate the current clinical and commercial landscapes by considering disease symptoms, pathogenesis, etiology, co-morbidities and complications, epidemiology, diagnosis, prognosis and treatment options for transplantation rejection.
• Identify leading products and key unmet needs within the market.
• Recognize trends in pipeline innovation by analyzing therapies by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary molecular target matrix assessment, first-in-class targets in the pipeline have been assessed and ranked according to clinical potential.
• Consider first-in-class pipeline products with no prior involvement in licensing and co-development deals, which may represent potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/935560
Scope
• There is a need for therapies that can achieve graft-specific immunosuppression, without having a general effect on the wider immune system. Which therapies and technologies currently in development are most likely to achieve this?
• There are 63 distinct first-in-class molecular targets in development for transplantation. Which of these hold the strongest potential in the clinic, and which are closest to reaching the market?
• How effective are current therapies for these indications, and how have they been able to improve the general prognosis in recent decades?
• Which molecule types and molecular targets are most prominent across transplantation therapy?
• Which specific types of transplantation are being most heavily studied across the pharmaceutical pipeline?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935560

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/transplantation-therapeutics-research-talks-about-leading-products-and-key-unmet-needs-within-the-market/314334

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-transplantation-therapeutics-a-highly-innovative-pipeline-with-a-range-of-adaptive-and-innate-immune-targeting-programs-focusing-on-graft-versus-host-disease-and-kidney-transplantation%20%20

Source: MarketersMedia

Release ID: 314334

Latest News

China-US ties sinking amid acrimony over trade, politics

Oct 23, 2018

BEIJING — "Both ignorant and malicious" was how the official China Daily newspaper recently described comments by U.S. Secretary of State Mike Pompeo, offering a stinging insight into the current bitter tone of discourse between the countries. The White House's move to expand Washington's dispute with Beijing beyond trade and technology and into accusations of political meddling has sunk relations between the world's two largest economies to the lowest level since the Cold War. A major speech by U.S. Vice President Mike Pence on Oct. 4 was the clearest, highest-level sign that U.S. strategy was turning from engagement to confrontation....

Trump wants to push middle-income tax cut through Congress

Oct 23, 2018

WASHINGTON — President Donald Trump says he wants to push a new middle-income tax cut through Congress after the midterm elections, though he's not offering specifics on the plan. Trump said Monday he's looking to cut taxes by about 10 percent for middle-income people. The proposal follows the massive tax law that Republicans muscled through Congress late last year and Trump signed as his major legislative achievement. With the midterm elections in two weeks, polls have shown only tepid support among voters for that package of individual and corporate tax cuts that took effect Jan. 1. It provides steep tax...

AP FACT CHECK: Trump on migrants, Saudis, Hispanic vote

Oct 23, 2018

WASHINGTON — President Donald Trump inflated the projected benefits of an arms deal with the Saudis as he defended his wait-and-see attitude about Saudi complicity in the disappearance of a journalist whose apparent murder has sparked world outrage. On immigration enforcement, the president made the unsubstantiated claim that migrants are being paid to mass at the border and somehow disrupt the Nov. 6 elections in the United States. Trump also stretched credulity when boasting about his performance with Hispanic voters at a rally and distorted facts concerning climate change and the Russia investigation in a recent interview with The Associated...

Cybersecurity 'Paul Revere' touts adversarial model

Oct 23, 2018

BURLINGTON, Mass. — Chris Wysopal and his Boston hacker collective pals from the L0pht sounded the alarm on the sad state of software vulnerability in a now-legendary 1998 appearance before Congress. Then-Sen. Joe Lieberman hailed the group as "modern-day Paul Reveres." Wysopal remains active in cybersecurity today as chief technology officer of Veracode, now part of CA Technologies. He spoke with The Associated Press recently on the state of security. Questions and responses have been edited for clarity and length. Q: How did Microsoft in 2002 come to embrace the mindset of allowing friendly, "white-hat" hackers to pick apart software...

AP FACT CHECK: Trump inflates jobs impact of Saudi arms deal

Oct 23, 2018

WASHINGTON — President Donald Trump inflated the projected benefits of an arms deal with the Saudis as he defended his wait-and-see attitude about Saudi complicity in the disappearance of a journalist whose apparent murder has sparked world outrage. On immigration enforcement, the president made the unsubstantiated claim that migrants are being paid to mass at the border and somehow disrupt the Nov. 6 elections in the United States. This claim followed his distortions in an Associated Press interview about climate change and the Russia investigation. A look at how some of his words over the past week stack up with...

Search
Financial Markets

About Us

Established in 2015, The Upstocker provides insights on financial reports, commentary, and investment data to traders so that you can make better investment decisions.

Contact us: sales[at]theupstocker.com

Subscribe Now!